The number of people with susceptibility test result for rifampicin in Maldives
Maldives: The number of people with susceptibility test result for rifampicin was 46 in 2021. ▼ Falling
Latest (2021)
46
Change on year
up 7.0%
World rank
123rd
of 155 countries
All-time high
108
in 2019
All-time low
43
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Maldives, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Maldives is 46, measured in 2021.
That represents a change of up 7.0% on the previous year and down 20.7% over five years.
Maldives ranks 123rd of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Maldives, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 58 | — |
| 2018 | 62 | +6.9% |
| 2019 | 108 | +74.2% |
| 2020 | 43 | -60.2% |
| 2021 | 46 | +7.0% |
Maldives compared with similar countries
- Maldives's 46 is below the median for upper middle income countries, which is 880, 5% of the median. (46 countries reporting)
- Maldives's 46 is below the median for South Asia, which is 11,863, 0% of the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 76 | 58 | 108 | 3 |
| 2020s | 44.5 | 43 | 46 | 2 |
Countries ranked near Maldives
More health data for Maldives
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -2.69 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,560 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.2 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0264 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.8 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Maldives?
- The number of people with susceptibility test result for rifampicin in Maldives was 46 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Maldives?
- The highest recorded value was 108 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Maldives?
- The lowest recorded value was 43 in 2020.
- How does Maldives rank for the number of people with susceptibility test result for rifampicin?
- Maldives ranks 123rd out of 155 countries with data for 2021.
- Where does this Maldives data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).